Fluxid Schwarz Pharma, Inc. - Treatment for Ulcers and other Gastrointestinal Conditions
Fluxid is new disintegrating tablet dosage form of famotidine indicated for the treatment of ulcers, gastroesophageal reflux disease and pathological hypersecretory conditions.Posted: September 2004
Fluxid (famotidine) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
